Hormone receptor status-Positive (ER and/or PR)-ER/PR- Posts on Medivizor
Navigation Menu

Hormone receptor status-Positive (ER and/or PR)-ER/PR- Posts on Medivizor

Looking for patients with estrogen receptor-positive breast cancer to test a new treatment combination

Posted by on May 11, 2019 in Breast cancer | 0 comments

In a nutshell This phase 2 trial will evaluate the safety and effectiveness of ribociclib (Kisqali) combined with hormonal therapy in patients with estrogen receptor-positive (ER+) breast cancer (BC). The main outcome will be the number of patients that complete 1 year of treatment and survival without signs of cancer. The trial will...

Read More

Looking for patients with hormone-receptor positive breast cancer to test a new treatment combination

Posted by on Apr 24, 2019 in Breast cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety of durvalumab (Imfinzi) in combination with standard hormonal treatment for breast cancer (BC). The main outcome will be the response to treatment. The trial is recruiting in Tampa, Florida, US. The details Breast cancer (BC) is one of the most common cancers. It affects bothe...

Read More

Overall survival with fulvestrant 500mg versus 250mg

Posted by on Apr 5, 2014 in Breast cancer | 0 comments

In a nutshell This study examined overall survival rates following treatment with different dosages of fulvestrant (Faslodex) in patients with recurrent or metastatic estrogen receptor-positive breast cancer. Some background Estrogen receptor-positive (ER+) breast cancers are dependent on the hormone estrogen for continued growth and spread....

Read More